MOWOOT

Development of a medical device for the treatment of irritable bowel syndrome (IBS).

The MOWOOT project develops the first medical device for the treatment of irritable bowel syndrome, a common disorder that causes abdominal pain and irregular bowel movements.

The device uses mechanical stimulation of the abdomen to interact with gastrointestinal mechanosensory cells and circuits, which are involved in the regulation of intestinal motility and sensitivity. The device also includes sensor technology and a digital platform with artificial intelligence to monitor and optimize treatment results.

MOWOOT is based on the latest research on the role of gastrointestinal mechanosensory cells in IBS and the potential benefits of abdominal massage.

In addition, MOWOOT has the following specific goals: understand the motility patterns of the healthy gut and IBS, develop and evaluate a specific treatment algorithm for IBS, develop hardware and sensor technology, develop the digital platform and evaluate the final prototype.

The project is carried out by a consortium of three partners: USMIMA, a company specialized in the development of medical devices for gastroenterology; Eurecat, technological center that will develop the device’s software, hardware and sensors; and IDIAPJGol, a research center that will conduct clinical trials and qualitative studies to evaluate the device.

In the case of Eurecat, the Digital Health Unit is involved, developing the digital platform, the self-management system and the AI algorithm, as well as the Product Innovation and Multiphysics Simulation Unit, which drives the belt prototype and sensory and connectivity.